QCell
QCell is a high quality, well-characterised panel of primary brain cancer cell line models for academic and commercial use.
QCell models have been extensively published in over 50 scientific journals including Cancer Cell, Nature Neuroscience, Acta Neuropathologica and Neuro-Oncology.
QCell patient-derived glioblastoma (GBM) cell lines are cultured to maintain genetic and epigenetic stability with enhanced tumourigenic potential in vivo. All models form intracranial xenograft tumours and can be obtained transduced with a luciferase expressing construct for in vivo bioluminescent tumour tracking.
Access and usage
Academic use
No restrictions are placed on QCell models for academic use and can be obtained under an approved Material Transfer Agreement (MTA) from QIMR Berghofer. Please provide contact information including primary contact details for the MTA, shipping address, phone number and a 50-word paragraph outlining the proposed project.
Send to LIST_qcell.glioma@qimrb.edu.au or Bryan.Day@qimrb.edu.au. Please note you will be required to cover the cost of cell line shipping.
Commercial use
QCell models are available for commercial “for profit” use and can be accessed under a license agreement from QIMR Berghofer. Please contact Professor Bryan Day at
Bryan.Day@qimrb.edu.au
Phone: +61 7 3845 3885 for further details and to initiate an agreement.
Contract Research
QCell also offers high quality contract research services to academic institutions, pharmaceutical, biotech, and healthcare providers. If you would like further information about our contract research team and resources, please contact: Prof Bryan Day at Bryan.Day@qimrb.edu.au.
Available resources
Xenograft survival times
Xenograft histology
Signalling pathway mutations
Proteomics profiling Qcell lines
Patient tumour histology
Nonsynonymous single nucleotide variants
MGMT promoter methylation status
Gene set enrichment analysis
GBM cell line culture
Demographic information
De-identified pathology reports
Cell line publications
Cell line morphology
Cell line flow cytometry
Cell line doubling time
Cell line antibiotic sensitivities
Cell line short tandem repeat STR profiles
Genome sequencing
RNA sequencing
| Line | Reference no. | Genome sequencing data |
| BAH1 | QIMR-B001 | BAH1 exome sequencing data (ZIP 16GB) |
| FPW1 | QIMR-B002 | FPW1 exome sequencing data (ZIP 6.3GB) |
| HW1 | QIMR-B003 | HW1 exome sequencing data (ZIP 6.1GB) |
| JK2 | QIMR-B004 | JK2 exome sequencing data (ZIP 5.9GB) |
| MMK1 | QIMR-B005 | MMK1 exome sequencing data (ZIP 5.8GB) |
| MN1 | QIMR-B006 | MN1 exome sequencing data (ZIP 6.6GB) |
| PB1 | QIMR-B007 | PB1 exome sequencing data (ZIP 5.5GB) |
| RKI1 | QIMR-B008 | RKI1 exome sequencing data (ZIP 6.0GB) |
| RN1 | QIMR-B009 | RN1 exome sequencing data (ZIP 6.2GB) |
| SB2b | QIMR-B010 | SB2b exome sequencing data (ZIP 5.7GB) |
| SJH1 | QIMR-B011 | SJH1 exome sequencing data (ZIP 5.3GB) |
| WK1 | QIMR-B012 | WK1 exome sequencing data (ZIP 16GB) |
| MD5 (128-bit) checksums | md5sum.txt |
Cell line depositors
Professor Bryan Day is the Group Leader of the Sid Faithfull Brain Cancer Laboratory at QIMR Berghofer and an internationally recognised expert in brain cancer.
Dr Brett Stringer MBBS PhD - Brain Cancer Research Fellow, Flinders University